Institutional Infrastructure
for Venture Capital
Syndication & Co-Investment

The potential mega-round for Anthropic highlights a structural shift in how value is created - and captured - in tech At this end of the market, capital is no longer fuel - it’s positioning.These rounds are less about “needing money” and more about:locking in strategic investorscontrolling the cap table ahead of an IPOsignalling category leadership, where perception compoundsThe important shift:A significant portion of value creation is now happening before companies ever reach the public markets.Historically:Amazon IPO’d at ~$0.4B -> now ~$2T+Nvidia at ~$0.6B -> now ~$4T+Google at ~$23B -> now ~$3T+Facebook at ~$100B -> now ~$1T+Most of the value creation - 100x+ - happened after listing.Today, that curve has shifted. Companies like Anthropic are raising at valuations that already price in a meaningful part of future outcomes - before IPO.Which demonstrates:private investors are capturing more of the upsidelate-stage rounds are absorbing what used to be public market gainspublic investors are increasingly underwriting execution, not discoverySo the question is no longer just: “Is this a great company?”It’s: “How much of the upside is already priced in — and what’s actually left?”In this environment, access matters and private markets matter are more important than ever. https://techcrunch.com/2026/04/29/sources-anthropic-could-raise-a-new-50b-round-at-a-valuation-of-900b/

Shanghai-based biotech innovator Vivacta Bio has completed Series A and Series A+ financing totaling over $50 million, strengthening its position in the fast-growing cell therapy market. The funding round reflects rising investor confidence in next-generation in vivo CAR-T therapies, a breakthrough area aiming to simplify and scale cancer and autoimmune treatments.The two rounds were led separately by Loyal Valley Capital and Decheng Capital, with participation from major healthcare investors including OrbiMed, Hankang Capital, Eisai Innovation Inc., C&D Emerging Industry Equity Investment, along with existing backers Qiming Venture Partners, Beijing Shunxi, and Apricot Capital. The diverse syndicate combines global biotech expertise with strategic growth capital.Founded by Dr. Liu Yarong, Vivacta Bio is focused on pioneering in vivo CAR-T cell therapy, an emerging approach that engineers immune cells directly inside the body rather than through complex ex vivo manufacturing. This model could significantly reduce treatment cost, improve access, and shorten time-to-therapy for patients.The company’s lead program GT801 has shown promising early safety and efficacy signals in studies involving hematological malignancies and autoimmune diseases. Initial human data was also presented at the American Society of Hematology (ASH) Annual Meeting 2025, increasing visibility for the platform among global clinicians and investors.Fresh capital will be used to accelerate clinical trials for GT801, support regulatory submissions, expand research capabilities, and drive global commercialization efforts. As biotech investors increasingly target transformative immune therapies, Vivacta Bio enters a critical scale-up phase.Vivacta’s latest raise also highlights continued momentum in China’s biotech ecosystem, where startups are advancing globally competitive innovation across oncology, autoimmune disease, and advanced therapeutics.

San Francisco-based infrastructure startup OpenObserve has secured $10 million in Series A funding to accelerate growth of its AI-native observability platform. The funding round reflects rising investor demand for modern monitoring and analytics tools as enterprises scale cloud infrastructure, distributed systems, and AI workloads. OpenObserve aims to disrupt legacy observability stacks with lower-cost, high-performance architecture.The round was led by Nexus Venture Partners and Dell Technologies Capital. Both investors had previously backed the company in earlier rounds and reportedly moved preemptively to fund this Series A due to strong enterprise traction and product momentum.OpenObserve offers a unified platform for logs, metrics, traces, real user monitoring, incident management, anomaly detection, and pipeline analytics. The company says its platform delivers 140x lower storage costs with zero database management, positioning it as a cost-efficient alternative to fragmented legacy tools such as ELK and Prometheus-Grafana stacks.The startup has already gained meaningful market adoption, with more than 6,000 organizations using its open-source platform, including multiple Fortune 100 enterprises. Its developer ecosystem has also expanded rapidly, crossing 18,000 GitHub stars, signaling strong open-source credibility.A major differentiator is OpenObserve’s new AI capabilities, including an AI-SRE layer that helps convert raw telemetry into operational intelligence. The platform also includes support for MCP and LLM observability, helping enterprises monitor AI applications alongside backend, frontend, network, and security systems.The fresh capital will likely be used for product innovation, go-to-market expansion, hiring, and deeper enterprise adoption. As AI workloads increase complexity across infrastructure environments, observability platforms like OpenObserve are becoming critical enterprise software layers.

Mumbai-based health and wellness marketplace HyugaLife has secured ₹100 crore (around $10.5 million) in Series A funding to accelerate growth across technology, supply chain, and omnichannel retail. The funding marks a significant milestone for one of India’s emerging consumer health commerce platforms focused on authentic supplements, proteins, and wellness products.The round was led by IvyCap Ventures, with participation from First Bridge Fund. HyugaLife has also previously attracted backing from Peak XV Partners and Spring Marketing Capital, reflecting sustained investor confidence in the company’s growth trajectory.Founded by Sachin Parikh, Anvi Shah, and Neehar Modi, HyugaLife operates a curated marketplace focused on solving trust issues in India’s supplements category. The platform sources directly from brands, avoids third-party sellers, and conducts independent lab testing for nutrition accuracy and heavy metal checks.The fresh capital will be used to strengthen AI-driven personalisation, helping users discover products aligned with life stage, fitness goals, and wellness needs. Funds will also support expansion of its dark store network for faster deliveries and the launch of an offline retail presence.HyugaLife currently offers more than 10,000 products across 450+ brands, serving athletes, professionals, and families across India. As wellness spending rises and consumers demand verified products, the company is well positioned to become a trusted omnichannel health platform.With consumer health, supplements, and AI-led commerce converging, HyugaLife’s latest raise highlights growing venture interest in India’s digital wellness economy.

U.S.-based defense technology startup Scout AI has secured $100 million in Series A funding, marking one of the largest early-stage defense tech financings in recent U.S. history. The oversubscribed round will accelerate development of the company’s autonomous warfare foundation model, as investors increasingly back AI-native national security platforms.The funding round was co-led by Align Ventures and Draper Associates, with participation from several strategic and institutional investors. The capital reflects growing demand for dual-use technologies that combine robotics, autonomy, and battlefield intelligence.Founded in 2024 by Coby Adcock and Collin Otis, Scout AI is building Fury, a foundation model designed for unmanned warfare systems. The platform is intended to power autonomous ground vehicles, drones, and other defense assets operating in contested environments with limited human intervention.Scout AI focuses on integrating software autonomy directly into ruggedized military hardware. This allows fleets of unmanned systems to coordinate missions, navigate complex terrain, and support logistics or tactical operations in real time. As modern militaries seek scalable autonomous capabilities, the company is targeting a rapidly expanding defense AI market.The new funding is expected to support model training, engineering hires, hardware testing, customer deployments, and partnerships across U.S. defense and allied security ecosystems. Scout AI has already gained visibility for field training exercises involving autonomous all-terrain vehicles.Scout AI’s latest round reflects a broader global trend where venture capital is moving into defense innovation, especially in AI, robotics, autonomous systems, and strategic infrastructure.

Prague-based fintech startup Tapaya has secured €1 million in pre-seed funding to transform how businesses accept in-person payments by replacing legacy payment terminals with software-based infrastructure. The round highlights growing investor demand for fintech platforms simplifying merchant payments, embedded finance, and next-generation checkout systems.The funding round was led by Passion Capital, with co-lead participation from Depo Ventures, alongside follow-on investment from BADideas.fund. The backing from early-stage European investors signals confidence in Tapaya’s vision to remove hardware dependency from offline commerce.Founded by Laura Ďorďová, Roman Kuchařík, and Petr Zahradník, Tapaya is building a software layer that combines compliance, processor integrations, and card-scheme connectivity into a single SDK. This allows developers to embed payment acceptance into Android devices, tablets, kiosks, iOS systems, and enterprise hardware without relying on dedicated card terminals.The company aims to significantly reduce integration timelines from many months to just days by abstracting complex certification and regulatory processes. As global merchants increasingly seek flexible omnichannel payment systems, Tapaya is entering a fast-growing market where software-first payment acceptance is becoming standard.Fresh capital will be used to secure PCI MPoC certification, expand proprietary payment infrastructure across Central and Eastern Europe, and prepare for emerging trends such as AI-powered agentic payments and the digital euro.As physical commerce digitizes rapidly, Tapaya’s funding round reflects a wider shift where payment hardware is being replaced by scalable software platforms.